RaySearch Laboratories AB announced an extension of its relationship with Centre hospitalier universitaire vaudois (CHUV) in Lausanne, Switzerland, which will include orders for RayStation RayCare and RayIntelligence. 

June 28, 2021 — RaySearch Laboratories AB announced an extension of its relationship withCentre hospitalier universitaire vaudois(CHUV) in Lausanne, Switzerland, which will include orders for RayStationRayCareand RayIntelligence.

CHUV has been a RayStation customer since 2017 and included in the order is additional RayStation functionality for automated treatment planning and segmentation using machine learning techniques and support forCyberKnifeplanning. CHUV will become one of the first centers to adopt RayStation’s planning functionality for the Accuray CyberKnife treatment delivery system.

The center will also fully replace its existing oncology information system with RayCare to coordinate and optimize its workflows and treatment management.

In addition, CHUV will be the first center to purchase RayIntelligence, the innovative cloud-based oncology analytics system launched in December 2020. The system simplifies data integration and supports analysis of patient and treatment populations, research activities and workflows.

Going forward, CHUV will conduct all majorradiation oncologyactivities including treatment planning, record and verify, workflow management and data analytics exclusively with RaySearch software.

RaySearch and CHUV will also work togheter on various dimensions of treatment optimization, operational efficiency including optimal machine utilization and the new treatment technique FLASH radiotherapy. CHUV has pioneered the development of this new technique which makes it possible to deliver the required dose to the patient in a few sessions each lasting a few seconds, rather than in conventional treatments requiring multiple sessions of several minutes.

Prof. Jean Bourhis, CHUV says: “The collaboration between RaySearch and CHUV is entering in a very promising phase, setting up at CHUV a single integrated software platform, connecting all our radiation oncology activities and combining a highly efficient digital workflow management, along with innovative artificial intelligence tools for contouring and dosimetry. We expect to markedly improve the global efficiency, along with increasing the quality and safety of our radiation oncology treatments”.

Johan Löf, founder and CEO, RaySearch, said: “We are very pleased to extend our relationship with CHUV, a world-class center with a focus on using advanced technology to benefit patients. By expanding the existing RayStation installation to a complete suite of RaySearch products at CHUV, we will be able to support an optimization of operational efficiency, improve treatment quality and through RayIntelligence capture all data for improved decision making and further personalize treatments”.

The combined order value is 1,8 M EURO excluding service agreement.

For more information:www.raysearchlabs.com

Related Content

Research has potential to address significant unmet need, identify biomarkers that determine response to treatment
News|Lung Imaging

August 10, 2022 — Mount Sinai is leading a team of lung cancer researchers that has been awarded a three-year, $500,000 ...

TimeAugust 10, 2022
arrow
Bot Image, an Omaha-based MRI medical device company has developed an AI-driven medical device CAD software to significantly improve the accuracy and speed of prostate cancer detection (CADe) and diagnosis (CADx).
News|Prostate Cancer

August 9, 2022 — Bot Image, an Omaha-based MRI medical device company has developed an AI-driven medical device CAD ...

TimeAugust 09, 2022
arrow
The U.S. Food and Drug Administration approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV infusion for the treatment of patients with unresectable (unable to be removed) or metastatic (spread to other parts of the body) HER2-low breast cancer.
News|2022世界杯篮球预选赛赛程

August 8, 2022 — The U.S. Food and Drug Administration approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV ...

TimeAugust 08, 2022
arrow
Dr. Milena Cavic, Institute for Oncology and Radiology of Serbia
News|Lung Imaging

August 8, 2022 — Representatives from the Diagnostics Working Group of the IASLC Early Detection and Screening Committee ...

TimeAugust 08, 2022
arrow
David Gerber, MD
News|Lung Imaging

August 8, 2022 — A clinical trial is only as powerful as its participants. For years, researchers have struggled to fill ...

TimeAugust 08, 2022
arrow
Under this collaboration, IBA will equip the proton therapy system and the proton gantry treatment room at the Fred Hutchinson Cancer Center with ConformalFLASH research functionality, which will enable preclinical research on FLASH therapy.
News|Proton Therapy

August 5, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, Fred ...

TimeAugust 05, 2022
arrow
Enhancing oncology model aims to improve patient-centered care, lower health care costs, and address health equity as part of President Biden’s Cancer Moonshot
News|Radiology Business

August 4, 2022 — The Biden Administration, through the U.S. Department of Health and Human Services and the Centers for ...

TimeAugust 04, 2022
arrow
News|世界杯2022赛程时间表

August 3, 2022 — The Jack Martin Fund (JMF) has built on its partnership with the Mount Sinai Health System to provide ...

TimeAugust 03, 2022
arrow
The oncology information systems market is projected to be worth $2.59 Bn by 2022 and is expected to grow to $5.4 Bn by 2032, at a CAGR of 7.8% from 2022 to 2032.
Feature|Oncology Information Management Systems (OIMS)

August 2, 2022 — The oncology information systems market is projected to be worth $2.59 Bn by 2022 and is expected to ...

TimeAugust 02, 2022
arrow
The American Lung Association created LUNG FORCE, a national movement to defeat lung cancer, the leading cancer killer of women and men.
Feature|Lung Imaging

August 1, 2022 — In recognition of World Lung Cancer Day, the American Lung Association announced new patient resources ...

TimeAugust 01, 2022
arrow
Subscribe Now